INTRODUCTION
The master regulator of mitosis, Cdc2/Cyclin B, is inhibited by phosphorylation of Cdc2 on T14 and Y15, catalyzed by the Myt1 and Wee1 kinases. At the G2/M transition, these phosphorylations are reversed by the Cdc25 phosphatase, leading to Cdc2/Cyclin B activation and mitosis (Lew and Kornbluth, 1996) .
During interphase, Cdc25 is inhibited by Ser287 phosphorylation (Xenopus Cdc25; Ser216 in human Cdc25C), and this inhibitory phosphorylation is maintained by DNAresponsive checkpoints (Kumagai et al., 1998a; Peng et al., 1997) . Ser287 is targeted by many kinases, including Chk1, Chk2, cTAK-1, PKA, p38, and MAPKAP kinase-2, suggesting that phosphorylation of this site may integrate multiple signaling inputs (Duckworth et al., 2002; Furnari et al., 1999; Manke et al., 2005; Peng et al., 1998) .
Cdc25 Ser287 phosphorylation provides a docking site for 14-3-3 protein (Dougherty and Morrison, 2004; Peng et al., 1997) . Although the role of this binding in regulating Cdc25 catalytic activity has been controversial, 14-3-3 masks a nuclear localization sequence, preventing Cdc25 nuclear translocation (Kumagai et al., 1998b; Yang et al., 1999) . A Cdc25 mutant that is neither phosphorylated at Ser287 nor binds 14-3-3 (Ser287A) promotes premature mitosis even in the presence of damaged or incompletely replicated DNA (Kumagai et al., 1998a; Peng et al., 1997) . At mitosis, Cdc25 activation follows Ser287 dephosphorylation and 14-3-3 dissociation. Although previous reports implied that 14-3-3 removal resulted from Ser287 dephosphorylation, we recently reported that 14-3-3 removal precedes and is required for Ser287 dephosphorylation by protein phosphatase 1 (PP1) (Margolis et al., 2003) . Thus, we hypothesized that factors controlling 14-3-3 removal might be key targets of DNA-responsive checkpoints.
Seeking to identify factors controlling 14-3-3 removal from Cdc25, we found that phosphorylation of Cdc25 on T138 by Cdk2 was required, explaining a previously reported role for Cdk2 in regulating mitotic entry (Guadagno and Newport, 1996; Margolis et al., 2003) . These data did not explain how 14-3-3 release might be checkpoint regulated as Cdk2 activity was reportedly constitutive throughout the cell cycle in the Xenopus egg extracts used for our analyses (Guadagno and Newport, 1996; Rempel et al., 1995) . This suggested that regulation of 14-3-3 release must be exerted at some other level.
Although Cdc25 is negatively regulated by Ser287 phosphorylation, a role for phosphorylation in activating Cdc25 has been proposed because PP2A can inhibit Cdc25. At doses that inhibit PP2A selectively, okadaic acid (OA) promotes Cdc25 activation and mitosis even when DNA-responsive checkpoints are activated (Clarke et al., 1993 , Izumi et al., 1992 Kumagai et al., 1998a) . Because PP2A has many substrates, the specific effects of PP2A ablation on Cdc25 have not been studied. Thus, it has not been clear how PP2A controls Cdc25 activation and whether this regulation might be under checkpoint control. In addition, the PP2A core enzyme, comprised of the catalytic subunit (C) and a structural subunit (A), can be directed to substrates by a number of different targeting subunits (B), and the targeting subunit involved in vertebrate Cdc25 regulation has not been identified.
We report here that checkpoint-regulated release of 14-3-3 from Cdc25 is controlled by PP2A bound to the B56d targeting subunit. Binding of PP2A/B56d to Cdc25 maintains T138 dephosphorylation (and stable 14-3-3 binding) during interphase. Importantly, Chk1 phosphorylation of B56d enhances PP2A-mediated T138 dephosphorylation, indicating that DNA-responsive checkpoints control Cdc25 through PP2A rather than simply through Ser287 phosphorylation. Although T138 phosphorylation is critical for 14-3-3 release from Cdc25, it is not sufficient. Rather, T138 phosphorylation reduces the affinity of 14-3-3 for Cdc25, but efficient 14-3-3 removal involves the creation of alternative docking sites for 14-3-3 on other proteins at G2/M. We show that this 14-3-3 sink consists, in Xenopus egg extracts, of phosphorylated keratin and propose that other abundant mitotically phosphorylated proteins may serve this role in other cell types. These data show that PP2A is checkpoint controlled through targeting subunit phosphorylation, suggesting that PP2A-mediated T138 dephosphorylation is the most upstream of the known regulatory events acting on Cdc25. In addition, our findings suggest a model in which the G2/M transition is driven in a concerted manner both through control of Cdc2 regulators and by phosphorylation of additional cellular proteins that serve as docking sites for 14-3-3.
RESULTS

T138-Directed Phosphatase Activity Is Cell-Cycle Regulated
The identification of Cdk2 as the T138-directed kinase raised the issue of how this phosphorylation might be regulated, since Cdk2 kinase activity is constitutive during the early Xenopus embryonic cell cycles (Guadagno and Newport, 1996) . T138 phosphorylation was absent in interphase egg extracts (prepared with cycloheximide to prevent Cyclin synthesis) and was induced by addition of recombinant Cyclin B to drive mitosis ( Figure 1A , left). (A) Wild-type (WT) and T138V GST-Cdc25 proteins were incubated in Xenopus egg interphase extract treated with Cyclin B1. Samples were retrieved on glutathione-Sepharose at the indicated times, washed, and immunoblotted with anti-pT138 antibody (left). Asynchronous (A), interphase (I, aphidicolin-treated), or mitotic (M, nocodazole-treated) HEK 293 cell lysates were immunoblotted with anti-pT138 antibody (right). (B) Cycling extract samples taken at the indicated times were immunoblotted for pT138 and pY15 Cdc2. The arrow indicates nuclear envelope breakdown. (C) WT or T138V GST-Cdc25 was incubated in interphase extract +/À OA treatment. Samples were retrieved on glutathione-Sepharose, washed, and immunoblotted for pT138. (D) N-terminal GST-Cdc25 was incubated in interphase extract +/À OA and +/À p21 and processed as in (C) for anti-pT138 blotting. (E) GST-Cdc25 protein was incubated in buffer containing ATP +/À Cdk2/Cyclin E for 1 hr at 30 C and processed as in (C).
(F) GST-Cdc25 was phosphorylated with Cdk2/Cyclin E, washed, and incubated in interphase extract (top) or in either interphase (I) or mitotic (M) extract (bottom). Samples were processed as in (C) for anti-pT138 immunoblotting. Similar cell-cycle variation in phosphorylation at this site was seen for endogenous Cdc25C in human HEK 293 cells (T130 in Cdc25C) ( Figure 1A , right). T138 phosphorylation appeared before Cdc2 activation in cycling egg extracts, as determined by Y15 dephosphorylation and nuclear envelope breakdown ( Figure 1B ; data not shown). These data raised the possibility that a T138-directed phosphatase was cell-cycle controlled. Consistent with this, addition of the phosphatase inhibitor, OA, to interphase extracts induced T138 phosphorylation ( Figure 1C) . Moreover, the Cdk2 inhibitor p21 diminished T138 phosphorylation in the OA-treated interphase extracts, confirming the role of Cdk2 in regulating 14-3-3 release from Cdc25 ( Figure 1D ). To demonstrate T138 dephosphorylation during interphase, we phosphorylated GST-Cdc25 with Cdk2 in vitro ( Figure 1E ), added this protein to interphase extracts, and retrieved the protein on glutathione-Sepharose at various times for anti-pT138 immunoblotting (Figure 1F, top) . As shown in Figure 1F (bottom), T138 was rapidly dephosphorylated in interphase, but not mitotic, extracts. Similar results were obtained with a radiolabeled phosphopeptide derived from Cdc25 (amino acids (aa) 108-200 containing T138 as its only phosphorylation site) ( Figures 1G and 1H ). These data show that T138-directed phosphatase activity is cell-cycle regulated and suggest that 14-3-3 release may be controlled by a T138-directed phosphatase. Indeed, OA induced release of 14-3-3 from Cdc25 in interphase extracts ( Figure 1I ).
Interphase Activation of T138-Directed PP2A Activity OA induction of T138 phosphorylation suggested that PP1 or PP2A might regulate T138 phosphorylation. As shown in Figure 2A , with concentrations of OA that inhibit PP2A, but not PP1, the interphase extract could not promote T138 dephosphorylation of in vitro-phosphorylated GST-Cdc25 (Margolis et al., 2003) . In addition, the selective PP2A inhibitor, fostriecin, prevented T138 dephosphorylation at concentrations that prevent dephosphorylation of a known PP2A substrate, phosphorylase A, arguing that PP2A dephosphorylates T138 in interphase extracts ( Figure 2B ; Margolis et al., 2003) .
PP2A activity is reportedly static during the cell cycle (Clarke et al., 1993; Ruediger et al., 1991) . Consistent with this, PP2A dephosphorylated phosphorylase A similarly in interphase and mitotic extracts, and no variation in PP2A activity occurred in a cycling egg extract ( Figures  2C and 2D) . Thus, we hypothesized that cell-cycle oscillation in T138 dephosphorylation resulted from a specific change in Cdc25-targeted PP2A activity.
B56d Mediates T138 Dephosphorylation
The PP2A core enzyme consists of a catalytic (C) subunit and a regulatory/scaffolding (A) subunit. A regulatory/targeting B subunit associates with the core, creating the holoenzyme (PP2A A/B/C) (Mumby and Walter, 1993) . We wished to determine whether PP2A A/B/C could bind to Cdc25 and, if so, which B subunit was present. As shown in Figures 3A and 3B, Cdc25 coprecipitated with PP2A/C in a 1:1 stoichiometry. In S. cerevisiae, two B subunits, Cdc55 (B55 in vertebrates) and RTS1 (B56) have been suggested to regulate Cdc25 (Minshull et al., 1996; Wang and Burke, 1997; Yang et al., 2000; D. Lew, personal communication) . Though we did not detect an interaction between Xenopus Cdc25 and B55, ( Figure 3D , bottom), B56 coprecipitated with Cdc25 from interphase extracts and was retrieved from extracts with GSTCdc25 ( Figures 3C and 3D, top) . Human Cdc25C also coprecipitated with HA-tagged B56 (d isoform) from transfected HEK 293 cells ( Figure 3E ). Using a B56d-specific antibody to immunoblot Xenopus extract and comparing the electrophoretic mobility of the recognized band to those in wild-type (WT) and B56d knockdown HEK 293 cell lysates, we identified the Xenopus Cdc25 bound B56 as B56d (Figures S1 and 3D, top) .
To determine if PP2A/B56d-Cdc25 binding was important for T138 dephosphorylation, we created a series of Cdc25 N-terminal fragments and assessed their PP2A/ B56d binding and susceptibility to T138 dephosphorylation. We found that aa 1-150 of Cdc25 bound weakly to PP2A/B56d, while larger N-terminal fragments interacted strongly ( Figure 3F ). Cdc25 peptides spanning aa 108-200 (containing the PP2A docking site) or 108-150 (lacking the docking site) were equally phosphorylated by Cdk2, yet only the 108-200 peptide was dephosphorylated in interphase extract ( Figure 3G , left and bottom right). In addition, incubation of unphosphorylated 108-150 peptide in interphase extracts resulted in net T138 phosphorylation, while incubation of the 108-200 peptide did not ( Figure 3G , top right), most likely because the 108-150 peptide could not be dephosphorylated.
To explore the role of B56d further, we performed multiple rounds of B56d immunodepletion from cytosolic interphase egg extract. After three depletions, it was not possible to precipitate additional B56d ( Figure 3H ). Following this depletion, pT138 accumulated on Cdc25 in an interphase extract ( Figure 3I ). Moreover, removal of immunoprecipitable B56 resulted in a failure to dephosphorylate T138 when we added Cdk2-phosphorylated Cdc25 to the extract, consistent with a critical role for B56 in T138 dephosphorylation ( Figure 3J ). These data suggest that association of B56d with Cdc25 is required for T138 dephosphorylation during interphase and that it is the T138-directed phosphatase, rather than Cdk2, that is cell-cycle regulated.
The DNA Replication Checkpoint Controls T138 Dephosphorylation Given the importance of 14-3-3 in maintaining checkpoint suppression of Cdc25 and the role of T138 phosphorylation in 14-3-3 release, we hypothesized that T138 dephosphorylation might be checkpoint regulated. To test this, we examined Cdc25 dephosphorylation in Xenopus egg extracts incubated with sperm chromatin and aphidicolin. As shown in Figure 4A , we found that T138 dephosphorylation was markedly accelerated by checkpoint activation.
Since T138 dephosphorylation was cell-cycle controlled, we speculated that alterations in PP2A/B56d-Cdc25 binding might underlie this regulation. Using recombinant proteins, we found that both PP2A A/C and B56d could interact directly and independently with Cdc25; however, neither interaction varied with the cell cycle ( Figures 4B-4D ). These data suggest that cell cycle-regulated T138 dephosphorylation was not the result of altered binding of PP2A or B56d to Cdc25.
Chk1 Phosphorylates B56d
Cdc25 suppression by the replication checkpoint is controlled by Chk1 and other checkpoint kinases. Therefore, we speculated that maintenance of this suppression by [g-32 P] release from phosphorylase A was measured by scintillation counting.
(D) PP2A was immunoprecipitated from cycling extracts at the indicated times, washed, and incubated with Threonine phosphopeptide. The pmoles of phosphate released were measured by colorimetric detection with Malachite Green Phosphate Detection Solution; results from three experiments were averaged, and error bars represent standard deviation (top). Cell-cycle progression was monitored by Cdc2-Y15 immunoblotting (bottom).
T138 dephosphorylation might also be controlled by checkpoint kinases. Accordingly, we examined in vitro T138 dephosphorylation by PP2A A/C with B56d in the presence and absence of Chk1. Interestingly, there was little T138 dephosphorylation in the absence of Chk1, and Chk1 markedly enhanced T138 dephosphorylation ( Figure 5A ). Importantly, prior incubation of B56d with Chk1 (with washes to remove Chk1), followed by incubation with Cdc25 and PP2A A/C, also enhanced T138 dephosphorylation ( Figure 5A ), suggesting that B56d might be a Chk1 target. Human B56d is a known phosphoprotein (McCright et al., 1996) , and B56 phosphorylation stimulates the activity of PP2A toward specific substrates in vitro (Usui et al., 1998) . Moreover, B56d could serve as an in vitro Chk1 substrate ( Figure 5B ). To identify the site(s) of phosphorylation, we used phospho-antibodies directed against four known phospho-sites on human B56d (Usui et al., 1998; J.H.A. and A.C.N., unpublished data) . Although only two of these sites are conserved in Xenopus B56d ( Figure S2 ), a phospho-Ser37 antibody recognized B56d in vitro phosphorylated by Chk1 ( Figure 5C ). In addition, the enhanced T138 dephosphorylation observed upon preincubation of B56 with Chk1 was lost when S37A mutant B56 was used in the reaction (data not shown). Moreover, Xenopus B56d added to interphase egg extracts was phosphorylated at S37 and dephosphorylated at mitosis, coincident with the appearance of pT138 ( Figures 5D and 5E ). Importantly, S37 phosphorylation on endogenous Xenopus B56d was enhanced by replication checkpoint activation and blocked by caffeine ( Figure 5F ). Under checkpoint conditions, B56d bound to Cdc25 was phosphorylated, and this phosphorylation was blocked by UCN-01, which inhibits Chk1 ( Figure 5G ). Consistent with this, an 85% knockdown of Chk1 protein by RNAi in HCT116 cells resulted in a marked loss of phosphorylated B56d ( Figure 5H ). Collectively, these data demonstrate that B56d serves as a Chk1 substrate, providing the first link between DNA-responsive checkpoints and PP2A B targeting subunits.
B56d Phosphorylation Enhances PP2A Holoenzyme Formation To determine if B56d S37 phosphorylation was important for interphase Cdc25 inhibition, we added B56d-S37A protein to egg extracts. As shown in Figures 6A and 6B , S37A, but not WT B56d, protein overrode a replication checkpoint. Consistent with the idea that B56d-Cdc25 interactions were not likely to be a key point of regulation, B56d WT and S37A mutant bound equally well to Cdc25 ( Figure 6C , top). In addition, in vitro phosphorylation of B56d with Chk1 did not alter its ability to bind recombinant Cdc25 ( Figure 6D ). Rather, B56d phosphorylation by Chk1 enhanced its ability to bind the PP2A core, suggesting that PP2A complex formation could be increased by checkpoint function ( Figure 6E ). Chk1 did not similarly enhance PP2A-B56d-S37A binding ( Figure 6F ). B56d-S37A protein was also impaired in its ability to bind endogenous Xenopus PP2A ( Figure 6C ). These data provided an explanation for the ability of the S37A mutant B56d protein to impair checkpoint suppression of Cdc25. Because S37 mutation diminished recruitment of PP2A A/C without impairing Cdc25 binding, we suspected that the S37A mutant acted in a dominant-negative fashion in egg extracts, docking on Cdc25 without interacting with the cobound PP2A core enzyme. This impairment would allow inappropriate accumulation of phospho-T138 even during interphase (or checkpoint arrest), as seen in Figure 6G . We also found that T138 dephosphorylation could be restored in extracts depleted of B56d if recombinant WT B56d, pretreated with Chk1, was added back to the depleted extracts. However, similarly treated B56d-S37A could not restore T138 dephosphorylation ( Figure 6H ). T138 dephosphorylation was somewhat slower in the depleted extracts supplemented with recombinant WT protein than in the mock (I) Preimmune-and B56d-depleted extracts were incubated at room temperature with energy-regenerating mix. Samples were withdrawn at the indicated times and immunoblotted for pT138 (arrow).
(J) GST-Cdc25 was phosphorylated in vitro with Cdk2/Cyclin E, washed, and incubated in preimmune-or B56d-depleted extracts. Samples were withdrawn at the indicated times, washed, and immunoblotted for pT138.
depleted extract, probably reflecting the presence of some inactive protein in the recombinant B56 preparation ( Figure 3J ). Consistent with a role for B56d-S37 phosphorylation in regulating PP2A subunit interactions, GST-B56d bound PP2A A/C poorly in Chk1-depleted extracts ( Figure 6I ). Note that in Figures 6C and 6I , the amounts of recombinant B56d used for the pull-downs were in excess of endogenous Cdc25 (which would bridge interactions of cobound proteins) in order to observe alterations in the ability of free A/C subunits (which constitute $50% of total PP2A A/C in egg extracts (Lin et al., 1998) to bind B56 after Chk1 phosphorylation. Thus, we propose that Chk1-mediated suppression of Cdc25 acts at two distinct points: Ser287 phosphorylation allows 14-3-3 docking, while enhancement of B56d-PP2A A/C association ensures that the 14-3-3 will remain docked.
Thr138 Phosphorylation Is Required but Not Sufficient for 14-3-3 Removal Upon completion of DNA replication, PP2A-mediated T138 dephosphorylation ceases, allowing 14-3-3 release. However, when we treated recombinant 14-3-3-bound Cdc25 with Cdk2/Cyclin E to phosphorylate T138, we did not see any gross change in 14-3-3 binding ( Figure 7A ). Nonetheless, Cdk2 phosphorylation of Cdc25 reduced the apparent affinity of 14-3-3 for Cdc25 ( Figure S3 ). Moreover, Cdk2/CyclinE treatment rendered 14-3-3 more susceptible to dissociation from Cdc25 by highsalt buffer ( Figure 7B ). These data suggest that T138 phosphorylation, while required to induce 14-3-3 release, is not sufficient, but simply ''loosens'' 14-3-3 binding. Consistent with this, isolation of 14-3-3-bound Cdc25 from interphase extracts followed by OA treatment allowed phosphorylation of Cdc25 at T138 (presumably by bound Cdk2, Figure 7D ) without affecting 14-3-3 removal ( Figure 7C ). These data suggest that a factor(s), present in the full extract ( Figure 1I ), but not associated with the precipitated complex, was required for efficient 14-3-3 release.
An Intermediate Filament Sink Contributes to 14-3-3 Removal from Cdc25
To identify the missing component(s) required for 14-3-3 release, we fractionated interphase egg extracts by ultracentrifugation at 200,000 3 g into cytosolic, light membrane, heavy membrane, and pelletable (glycogen, ribosomes, assembled cytoskeletal proteins, and large protein complexes) fractions. Addition of OA (or Cyclin B) to the cytosol did not induce 14-3-3 release from GST-Cdc25 ( Figure 7E , data not shown). Adding each of the other fractions back, we restored 14-3-3 removal upon addition of the pelleted fraction to OA-treated cytosol ( Figure 7F ). Interestingly, pretreatment of total extract with OA prior to pelleting or using mitotic, rather than interphase, extract, as a source of pelleted material, generated 14-3-3-releasing activity in the pure cytosol, relieving the requirement for the pellet ( Figure S4A ). These data implied that the pelleted fraction contained a component required for 14-3-3 removal and that the active principle was pelletable during interphase but cytosolic in mitosis (or in the presence of OA to promote pseudomitotic phosphorylations). Interestingly, addition of 14-3-3 to extracts to double the endogenous concentration (40 mg/ml) suppressed both 14-3-3 release from Cdc25 and mitotic entry ( Figure S5) . In considering this, we noted a publication by Tzivion et al. (2000) in which treatment of COS-7 cells with the phosphatase inhibitor calyculin A resulted in the abundant association of phosphorylated vimentin with 14-3-3 at the expense of most other 14-3-3 protein complexes. From this, they hypothesized that phosphovimentin (and perhaps other intermediate filament proteins such as keratins) might, under specific physiological conditions, provide high-affinity binding sites to sequester 14-3-3. From this, we speculated that addition of excess 14-3-3 to our extracts neutralized the 14-3-3 sink provided by phosphorylated intermediate filament proteins, limiting their ability to promote 14-3-3 removal from Cdc25, thereby preventing mitotic entry.
Because 14-3-3 releasing activity was soluble in mitosis (or OA-induced pseudomitosis) but pelletable in interphase, we hypothesized that the activity might reside in an intermediate filament protein that would be polymerized in interphase (pelletable) and monomeric (soluble) in mitosis. Therefore, relevant proteins pelleted during interphase ought to be released into the cytosol during mitosis to create a 14-3-3 sink. To evaluate this, we pelleted interphase extracts and marked all precipitated proteins by biotinylation. The biotinylated proteins were then added to cytosolic interphase extracts treated with OA. The extracts were refractionated by centrifugation and the soluble cytosolic proteins were bound to a GST-14-3-3 resin, resolved by SDS-PAGE and probed with horseradish peroxidase (HRP)-streptavidin ( Figure S6 ). This resulted in the capture of a small number of 14-3-3 binding partners that had transitioned from a pelletable to a soluble state ( Figure 7G ).
Given the hypothesis that prompted these experiments, we were struck by the presence of abundant proteins of 48 and 55 KD, the molecular weights of keratin 8/18, in the profile of 14-3-3 binding partners. Because cells from keratin knockout animals reportedly show defects in G2/M progression (in some cell types), keratins were attractive candidates for the 14-3-3 binding sink (Toivola et al., 2001) . Moreover, keratin 8/18 complexes are phosphorylated and bind 14-3-3 at mitosis (Ku et al., 1998; Ku et al., 2002; Liao and Omary, 1996) . Interestingly, OA treatment of egg extracts or use of mitotic extract induced keratin 18 binding to 14-3-3, suggesting that phosphatase inhibition is sufficient to allow phosphorylation of keratin at 14-3-3 binding sites to similar levels observed during mitosis ( Figure 7H ). Given these data, we wished to determine whether keratin depletion/add-back affected 14-3-3-releasing activity. We found that 200,000 3 g ultracentrifugation of interphase extract removed >90% of the keratin, while OA or Cyclin B preincubation caused an almost complete release of keratin 18 into the cytoplasm (Figure 7I) . Thus, we considered the cytosol to be a keratindepleted extract, which was deficient in 14-3-3-releasing activity ( Figure 7J, top) . We then added back nanomolar quantities of keratin 8/18 protein to the cytosolic extract and measured 14-3-3 release in the presence or absence of OA ( Figure 7J, bottom) . Interestingly, keratin addition ($140 nM) effectively restored 14-3-3 release. We also found that addition of keratin back to ultraspun cytosol accelerated entry into mitosis driven by added Cyclin B, as measured by Cdc2 Y15 dephosphorylation and nuclearenvelope breakdown ( Figure 7K ; data not shown). Moreover, in cycling egg extracts, keratin binding to 14-3-3 occurred in advance of Y15-Cdc2 dephosphorylation, consistent with a role for keratin in Cdc25 activation (Figure 7L) . Additionally, immunofluorescent staining of synchronized HeLa cells demonstrated that keratin 18 phosphorylation at a previously characterized 14-3-3 binding site occurred prior to mitotic entry and in the presence of OA ( Figures S4B and S4C) (Ku et al., 1998) . In aggregate, these data suggest that the reduction in affinity for 14-3-3 caused by PP2A/B56d regulation and consequent accumulation of pT138 on Cdc25 could promote 14-3-3 removal due to the coincident mitotic phosphorylation of intermediate filaments to create a 14-3-3 sink. Together, these processes would allow efficient Cdc25 activation, dephosphorylation of Cdc2, and mitotic entry.
DISCUSSION
Regulation of PP2A/B56d by DNA-Responsive Checkpoints DNA-responsive checkpoints control mitotic entry, in part, by suppressing Cdc25 activation. While Ser287 phosphorylation by checkpoint kinases allows 14-3-3 docking and Cdc25 inhibition, we show here that maintaining this binding relies upon continued T138 dephosphorylation by PP2A/B56d. Thus, PP2A/B56d represents a novel checkpoint component. We have not yet determine if this regulatory pathway controls human Cdc25 proteins, though we note the conservation of T138 and 14-3-3 binding across isoforms (Figure S7 ).
(G) Interphase extracts with Cyclin B were treated with aphidicolin in the presence of GST, B56d, or B56d-S37A. Samples were taken at the indicated times and analyzed for pT138 phosphorylation. (H) WT or B56d-S37A protein was preincubated with His-Chk1 in buffer containing ATP at 30 C before being added to B56d-depleted cytosolic extracts. GST-Cdc25 T138 dephosphorylation was monitored by removing samples at the indicated times, washing, and immunoblotting with anti-pT138 antibody.
(I) GST-B56d was incubated in interphase extracts immunodepleted of Chk1, retrieved, washed, and immunoblotted for pS37, B56d, and PP2A (left). Mock or Chk1-depleted extracts were immunoblotted for Chk1 (right). Arrow indicates Chk1. Figure 7 . A Keratin 14-3-3 Sink Promotes 14-3-3 Release from Cdc25
(A) Cdc25-14-3-3 complexes isolated from interphase extract were washed and incubated +/À Cdk2/CyclinE at 30 C for 1 hr. Samples were washed with ELB + 300 mM NaCl and 0.1% Triton X-100 and immunoblotted with anti-14-3-3 sera.
Because Ser287 is phosphorylated during an unperturbed interphase, it has been speculated that checkpoint activation simply prolongs phosphorylation of this site until DNA damage is repaired or replication is completed (Sanchez et al., 1997; Zeng et al., 1998) . Indeed, checkpoint activation by DNA damage during interphase does not result in a marked increase in total Ser287 phosphorylation (Stanford and Ruderman, 2005) . Once DNA is repaired or replication is completed, loss of checkpoint kinase activity is not sufficient to promote Cdc25 activation because removal of 14-3-3 is required to allow Ser287 dephosphorylation. Thus, DNA-responsive checkpoints must directly control 14-3-3 removal, which occurs independently of and prior to Ser287 dephosphorylation. Our data suggest that 14-3-3 removal is controlled through checkpoint regulation of T138 dephosphorylation.
Unlike Ser287 phosphorylation, B56d phosphorylation is dynamically controlled by checkpoints. This phosphorylation enhances interaction of the PP2A A/C complex with B56d, providing the first evidence of checkpoint modulation of PP2A holoenzyme composition. These data also suggest that Cdc25 serves as a scaffold for B56d and PP2A A/C as both of these proteins bind independently to Cdc25 but are enhanced in their ability to interact with each other following checkpoint activation.
Keratin Phosphorylation Promotes 14-3-3 Release from Cdc25 Cdc25-T138 phosphorylation reduces 14-3-3 affinity sufficiently that an increase in the availability of other 14-3-3 binding sites at mitosis promotes 14-3-3 dissociation. We were surprised to identify keratin as a potential driver of mitotic entry. These data are consistent with the prescient prediction of Avruch and colleagues that phosphorylated 14-3-3 binding intermediate filament proteins might alter signaling pathways through 14-3-3 sequestration (Tzivion et al., 2000) . Interestingly, K8-null hepatocytes exhibit mislocalized 14-3-3 protein as well as elevated numbers of PCNA-positive S/G2-phase cells with doubled DNA content, suggestive of a 14-3-3 mediated G2 arrest (Toivola et al., 2001) . Although these data may indicate that the relevant sink in liver cells (as in egg extracts) is keratin, we propose that other abundantly phosphorylated proteins might perform this role in other cell types. A recent report implicating K17-14-3-3 interactions in the regulation of protein synthesis in epithelial cells also points to a broader role of keratins in controlling fundamental cellular processes (Kim et al., 2006) .
We have not yet identified the keratin-directed kinase, though it is not likely to be Cdc2, because OA treatment of interphase extracts, which lack Cyclin B, promotes keratin-14-3-3 interactions. We observed 14-3-3 release from Cdc25 upon OA treatment of complete extracts because this led to both keratin phosphorylation and T138 phosphorylation. Whether PP2A/B56d also dephosphorylates keratin is unknown. We also note that Cdc2/Cyclin B might create novel 14-3-3 binding sites on keratin, thereby contributing to positive feedback activation of Cdc25 by Cdc2.
A Model for Cdc25 Activation
We suggest that the following events control Cdc25 activation ( Figure S8 ): during interphase, Ser287 is phosphorylated and 14-3-3 is bound. When replication is ongoing, checkpoint kinases phosphorylate S37 of B56d, maintaining T138 dephosphorylation. Upon completion of replication, checkpoint kinases are turned off. We speculate, based on previously published work, that PP2A can then autodephosphorylate (Inoue et al., 1999; Tanabe et al., 1996) . Once B56d is dephosphorylated, pT138 accumulates through constitutive Cdk2 action. Once sufficient levels of phosphorylated sink proteins are achieved (B) The same experiment as in (A) was performed, but samples were washed with buffer containing increasing NaCl concentrations. (C) Cdc25-14-3-3 complexes were isolated as in (A) and incubated +/À OA at 30 C for 1 hr. Samples were collected, washed, and immunoblotted with anti-14-3-3 and anti-pT138 antibodies. (D) GST or GST-Cdc25 linked to glutathione-Sepharose was incubated in interphase extract, washed, and processed for immunoblotting with antiCdk2 antibody.
(E) GST-Cdc25-14-3-3 complexes were added to crude or cytosolic interphase egg extracts +/À OA. Samples were washed and immunoblotted with anti-14-3-3 sera. (F) Extract was spun at 200,000 3 g. Four reactions were generated by either mixing all fractions together (reconstituted), cytosol alone, cytosol + membrane, or cytosol + pellet. 14-3-3 bound GST-Cdc25 was incubated in each reaction + OA. Samples were collected at the indicated times, washed with ELB + 300 mM NaCl and 0.1% Triton X-100, and immunoblotted for GST and 14-3-3.
(G) Crude interphase extract was spun at 200,000 3 g. Pelleted proteins were biotinylated, added to cytosol, and incubated with dimethyl sulfoxide or OA for 1 hr and repelleted at 200,000 3 g. GST-14-3-3 or GST was incubated in each extract for 1 hr at 4 C. Samples were collected, washed, and resolved by SDS-PAGE and probed with HRP-streptavidin. (H) A similar experiment to that in (G) was done using nonbiotinylated pelleted protein, and samples were immunoblotted with anti-keratin sera (top). The experiment was also performed using mitotic cytosol (bottom).
(I) Crude extract +/À OA or Cyclin B was spun at 200,000 3 g. Cytosolic extracts were treated with OA, and aliquots were taken for anti-keratin and actin immunoblotting. (J) Equal amounts of 14-3-3 bound GST-Cdc25 were incubated at room temperature for 1 hr in cytosolic extract +/À OA with 71 nM or 142 nM keratin 8/18. GST-Cdc25 was retrieved on glutathione-Sepharose, washed, and immunoblotted with anti-pT138 and anti-14-3-3.
(K) Keratin 8/18 or GST was added to cytosolic extract in the presence of light membrane and sperm chromatin. Nondegradable Cyclin was added to extracts, and samples were taken at the indicated times and immunoblotted with anti-pY15 of Cdc2.
(L) GST-14-3-3 was incubated in cycling egg extract, retrieved at the indicated times on glutathione-Sepharose, washed, and immunoblotted with anti-keratin. Entry into mitosis was monitored by anti-Y15-Cdc2 immunoblotting.
(e.g., phospho-keratin), 14-3-3 is released, allowing PP1 to dephosphorylate Ser287 and activate Cdc25. Cdc25 activates Cdc2/Cyclin B, which further activates Cdc25 (Margolis et al., 2006) . Although Ser287 phosphorylation of Cdc25 must be maintained to sustain checkpoint inhibition of Cdc25, our data demonstrate that a critical component of checkpoint regulation lies with the PP2A-mediated dephosphorylation of T138 and consequent release of 14-3-3.
EXPERIMENTAL PROCEDURES
Cloning and Protein Expression N-terminal Cdc25 was cloned into pGEX-KG as described in Yang et al. (1999) . Xenopus B56d was cloned from a Xenopus cDNA library using 5 0 -CATGCCATGGGAATGCCTAATAAAAACAAGAAAGATAAA GAACCTCC-3 0 and 5 0 -CCGCTCGAGTCAAGTAAGGGCCCATCTGTT TCC-3 0 . GST-B56d-S37A was generated using the QuikChange Mutagenesis Kit (Stratagene). HA-B56 proteins were cloned into pCEP4-Lerner (McCright et al., 1996) . Keratin 8/18 was purchased from Prospec-Tany TechnoGene LTD. GST-14-3-33 was expressed as described (Kumagai et al., 1998b) .
Antibodies
Rabbit polyclonal anti-pT138 was raised against the peptide LPHLLCSpTPSFKKAC. B56d antibody was raised and affinity purified using the peptide QSQPPSSNKRPSNS (aa 49-62 of human B56d). Phospho-B56 antibody was raised against KRPpSNSTP. Anti-14-3-33 (Santa Cruz), anti-PP2A (Upstate), anti-pan-B56 (Upstate), anti-phospho-Cdc2 (Y15; Cell Signaling Technology), anti-Cdc25C (Abcam), anti-cdk2 (Abcam), anti-keratin C11(Sigma), and anti-keratin-18 (Lab Vision) antibodies were purchased.
Xenopus Extracts
Xenopus egg extracts and sperm chromatin were prepared as described (Murray, 1991) . Interphase extracts contained cycloheximide to prevent Cyclin synthesis, while cycling extracts were prepared after egg activation without cycloheximide. Nuclei stained with Hoechst 33258 were examined using a Zeiss Axioscop with a 40x Plan-Neofluar air objective.
Cell Culture and Chk1 Knockdown HeLa and HEK 293 cells were grown in Dulbecco's Modified Eagle's Medium (Gibco) with 10% fetal bovine serum (FBS). HCT116 cells were grown in McCoy's 5A Medium Modified (Gibco) with 10% FBS. Cells were transfected using PLUS reagent and Lipofectamine (Invitrogen). Where noted, cells were treated with 5 mg/ml aphidicolin or 40 ng/ ml nocodazole for 20 hr prior to harvest. Oligonucleotides targeting human Chk1 (5 0 -CAGGAGAGAAGGCAATATC-3 0 and its compliment)
were cloned into pSUPER, and HCT116 cells were transfected with Fugene 6 (Roche). Stable clones were selected with 500 mg/ml G418, grown to confluency and examined for Chk1 expression by immunoblotting.
Protein Phosphorylation/Dephosphorylation
To generate phosphorylated GST-Cdc25, Cdk2/Cyclin E (Upstate) and 2 mg of GST-Cdc25 were incubated in kinase buffer (10 mM Tris-HCl pH 7.5, 10 mM MgCl 2 , 1 mM DTT, 100 mM ATP) for 1 hr at 30 C.
Xenopus B56d was phosphorylated by incubating 2 mg GST-B56d or GST-B56d-S37A with recombinant His-Chk1 in kinase buffer for 1 hr at 30 C.
Phosphorylated GST-Cdc25 bound to glutathione-Sepharose was dephosphorylated in phosphatase buffer (50 mM Tris-HCl pH 7.5, 1 mM EDTA, 0.1% b-mercaptoethanol) supplemented with Xenopus egg extract or purified PP2A A/C (Upstate) and recombinant B56d and Chk1. PP2A activity was measured in cycling extracts using the PP2A Immunoprecipitation Phosphatase Assay Kit (Upstate).
Coprecipitation and Immunodepletions
To analyze interactions between Cdc25 and PP2A or B56d, GSTCdc25 proteins were incubated in interphase extract for 1 hr at 4 C, retrieved on glutathione-Sepharose, washed with egg lysis buffer (ELB: 250 mM sucrose, 2.5 mM MgCl 2 , 1 mM dithiothreitol [DTT] , 50 mM KCl, 10 mM Hepes pH 7.7) plus 150 mM NaCl and 0.05% Triton X-100, and immunoblotted with anti-PP2A or anti-B56d. GST-Cdc25-14-3-3 complexes were washed with ELB + 300 mM NaCl and 0.1% Triton X-100. To analyze purified protein interactions, N-terminal GST-Cdc25 or GST was incubated with PP2A A/C (Upstate) in ELB + 0.1% bovine serum albumin. Proteins were incubated at 4 C for 1 hr and washed with ELB + 150 mM NaCl and 0.05% Triton X-100 and analyzed by immunoblotting. GST-B56d or GST-B56d-S37A was incubated with PP2A A/C and His-Chk1 in kinase buffer for 1 hr at 30 C before washing and immunoblotting. Cytosolic interphase extract was depleted of Chk1 as reported (Kumagai et al., 1998a) and was depleted of B56d by three sequential 30 min incubations with 10 mg purified polyclonal anti-B56d serum coupled to protein A-Sepharose.
To analyze human protein interactions, cell lysates were prepared as described (Eide et al., 2002) . HA-tagged proteins were immunoprecipitated from 300 mg total protein with anti-HA antibody (Santa Cruz, CA) and collected with 20 ml protein A agarose (Invitrogen). Beads were washed with lysis buffer (150 mM NaCl, 30 mM HEPES pH 7.4, 0.1% Tween 20) and immunoblotted. Proteins were biotinylated using the ECL Biotinylation Module (Amersham) and quenched with the Avidin/ Biotin Blocking Kit (Zymed).
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